Biological sample collection and processing for molecular epidemiological studies

被引:176
作者
Holland, NT [1 ]
Smith, MT [1 ]
Eskenazi, B [1 ]
Bastaki, M [1 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
关键词
molecular epidemiology; biorepository; biomarkers; quality assurance; quality control;
D O I
10.1016/S1383-5742(02)00090-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Molecular epidemiology uses biomarkers and advanced technology to refine the investigation of the relationship between environmental exposures and diseases in humans. It requires careful handling and storage of precious biological samples with the goals of obtaining a large amount of information from limited samples, and minimizing future research costs by use of banked samples. Many factors, such as tissue type, time of collection, containers used, preservatives and other additives, transport means and length of transit time, affect the quality of the samples and the stability of biomarkers and must be considered at the initial collection stage. An efficient study design includes provisions for further processing of the original samples, such as cryopreservation of isolated cells, purification of DNA and RNA, and preparation of specimens for cytogenetic, immunological and biochemical analyses. Given the multiple uses of the samples in molecular epidemiology studies, appropriate informed consent must be obtained from the study subjects prior to sample collection. Use of barcoding and electronic databases allow more efficient management of large sample banks. Development of standard operating procedures and quality control plans is a safeguard of the samples' quality and of the validity of the analyses results. Finally, specific state, federal and international regulations are in place regarding research with human samples, governing areas including custody, safety of handling, and transport of human samples, as well as communication of study results. Here, we focus on the factors affecting the quality and the potential future use of biological samples and some of the provisions that must be made during collection, processing, and storage of samples, based on our experience in the Superfund Basic Research Program and Children's Environmental Health Center, at the University of California, Berkeley. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:217 / 234
页数:18
相关论文
共 99 条
[1]   IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans [J].
Albertini, RJ ;
Anderson, D ;
Douglas, GR ;
Hagmar, L ;
Hemminki, K ;
Merlo, F ;
Natarajan, AT ;
Norppa, H ;
Shuker, DEG ;
Tice, R ;
Waters, MD ;
Aitio, A .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 463 (02) :111-172
[2]   Collection of genomic DNA by the noninvasive mouthwash method for use in pharmacogenetic studies [J].
Andrisin, TE ;
Humma, LM ;
Johnson, JA .
PHARMACOTHERAPY, 2002, 22 (08) :954-960
[3]  
[Anonymous], 1993, MOL EPIDEMIOLOGY PRI
[4]   Absence of direct delivery for single transmembrane apical proteins or their "secretory" forms in polarized hepatic cells [J].
Bastaki, M ;
Braiterman, LT ;
Johns, DC ;
Chen, YH ;
Hubbard, AL .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (01) :225-237
[5]  
Beck JC, 2001, CANCER EPIDEM BIOMAR, V10, P551
[6]   Molecular epidemiology [J].
Boffetta, P .
JOURNAL OF INTERNAL MEDICINE, 2000, 248 (06) :447-454
[7]   Biomarkers in molecular epidemiology studies for health risk prediction [J].
Bonassi, S ;
Au, WW .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2002, 511 (01) :73-86
[8]  
Borzini P, 2000, HAEMATOLOGICA, V85, P885
[9]   Design and operation of a current good manufacturing practices cell-engineering laboratory [J].
Burger, SR .
CYTOTHERAPY, 2000, 2 (02) :111-122
[10]   Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays [J].
Bustin, SA .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (02) :169-193